The genome provides instructions for synthesis of proteins and non-coding RNAs.1 The epigenome provides further instructions on where to express a protein or RNA as well as how much of each to synthesize.1-3 Dysregulation of the epigenome in cancer cells may lead to aberrant gene expression of oncogenes and decreased expression of tumor suppressor genes.1-3
Celgene is developing a diverse array of therapeutics to target all major components of the cancer epigenome.
Modifying Epigenetic Regulation in Cancer Treatment
Cao J. Biol Proced Online. 2014;16:11.
Tarakhovsky A. Nat Immunol. 2010;11:565-568.
Roy DM, Walsh LA, Chan TA. Protein Cell. 2014;5:265-296.
Please Keep Me Informed
Provide your email address to receive monthly updates on Celgene’s research, news, and developments.
To view To return to www.researchoncology.com